ICU.US SeaStar Medical Holding Corporation

Healthcare Biotechnology USA Stocks
0.8384 USD
Close of Nov 15, 2026
0.8050 5.38
Market cap
USD 4.46M
P/E
-
P/B
1.04x
ROE
-3,349.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is ICU.US undervalued?

Graham number

The Graham number of SeaStar Medical Holding Corporation cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

SeaStar Medical Holding Corporation fundamental analysis

No fundamental analysis for SeaStar Medical Holding Corporation yet.

SeaStar Medical Holding Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About SeaStar Medical Holding Corporation

SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute ki…

Full company profile